JON JARVIS: Open Payments
NPI 1225524812 · MUNFORDVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 27 payments from 13 companies in 2025. Trend: 2023 $81 · 2024 $359 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $81 |
| GlaxoSmithKline, LLC. | 5 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Corium, LLC | 4 | $54 |
| Novo Nordisk Inc | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Amgen Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| Cipher Pharmaceuticals US LLC | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: CAPLYTA, REXULTI, TRELEGY ELLIPTA, Azstarys, FANAPT, Rybelsus, OTEZLA, Natroba.
Industry payments across KY — which companies pay providers there.
